S. Stewart, More ???malignant??? than cancer? Five-year survival following a first admission for heart failure, European Journal of Heart Failure, vol.35, issue.suppl A, pp.315-337, 2001.
DOI : 10.1016/S1388-9842(00)00141-0

A. Gabet, A. Lamarche-vadel, F. Chin, Y. Jullière, C. De-peretti et al., Mortalité due à l'insuffisance cardiaque en France, 2000.

D. Peretti, C. Pérel, C. Tuppin, P. Iliou, M. Juillière et al., Prévalences et statut fonctionnel des cardiopathies ischémiques et de l'insuffisance cardiaque dans la population adulte en France : apports des enquêtes déclaratives « Handicap-Santé, Bull Epidémiol Hebd, pp.9-10172, 2014.

M. Jessup, N. Banner, and S. Brozena, Optimal Pharmacologic and Non-pharmacologic Management of Cardiac Transplant Candidates: Approaches to Be Considered Prior to Transplant Evaluation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates???2006, The Journal of Heart and Lung Transplantation, vol.25, issue.9, pp.1003-1023, 2006.
DOI : 10.1016/j.healun.2006.06.007

J. Mcmurray, S. Adamopoulos, S. Anker, A. Auricchio, M. Böhm et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012, Developed in collaboration with the Heart Failure Association (HFA) of the ESC, pp.1787-1847, 2012.
DOI : 10.1016/j.repce.2013.10.001

C. Barnard, The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town, S Afr Med J, vol.41, pp.1271-1275, 1967.

. Agence-de-la-biomédecine, Greffe cardiaque

L. Lund, L. Edwards, and A. Kucheryavaya, The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report???2013; Focus Theme: Age, The Journal of Heart and Lung Transplantation, vol.32, issue.10, pp.951-64, 2013.
DOI : 10.1016/j.healun.2013.08.006

K. Lietz and L. Miller, Improved Survival of Patients With End-Stage Heart Failure Listed for Heart Transplantation, Journal of the American College of Cardiology, vol.50, issue.13, pp.1282-90, 1990.
DOI : 10.1016/j.jacc.2007.04.099

A. Rana, A. Gruessner, and V. Agopian, Survival Benefit of Solid-Organ Transplant in the United States, JAMA Surgery, vol.150, issue.3, p.252, 2015.
DOI : 10.1001/jamasurg.2014.2038

M. Mehra, J. Kobashigawa, and R. Starling, Listing Criteria for Heart Transplantation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates???2006, The Journal of Heart and Lung Transplantation, vol.25, issue.9, pp.1024-1066, 2006.
DOI : 10.1016/j.healun.2006.06.008

M. Alraies and P. Eckman, Adult heart transplant: indications and outcomes, J Thorac Dis, vol.6, pp.1120-1128, 2014.

J. Butler, M. Stankewicz, and J. Wu, Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation, The Journal of Heart and Lung Transplantation, vol.24, issue.2, pp.170-177, 2005.
DOI : 10.1016/j.healun.2003.09.045

S. Klotz, M. Deng, and D. Hanafy, Reversible pulmonary hypertension in heart transplant candidates-pretransplant evaluation and outcome after orthotopic heart transplantation, European Journal of Heart Failure, vol.41, issue.III, pp.645-53, 2003.
DOI : 10.1016/S1388-9842(03)00059-X

V. Jeevanandam, S. Furukawa, T. Prendergast, B. Todd, H. Eisen et al., Standard criteria for an acceptable donor heart are restricting heart transplantation, The Annals of Thoracic Surgery, vol.62, issue.5, pp.1268-75, 1996.
DOI : 10.1016/0003-4975(96)00626-1

J. Zaroff, B. Rosengard, and W. Armstrong, Consensus Conference Report: Maximizing Use of Organs Recovered From the Cadaver Donor: Cardiac Recommendations: March 28-29, 2001, Crystal City, Va, Circulation, vol.106, issue.7, pp.836-877, 2002.
DOI : 10.1161/01.CIR.0000025587.40373.75

G. Mudge, S. Goldstein, and L. Addonizio, 24th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization, J Am Coll Cardiol, vol.22, pp.15-20, 1993.

M. Costanzo, M. Costanzo, A. Dipchand, R. Starling, A. Anderson et al., The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients, The Journal of Heart and Lung Transplantation, vol.29, issue.8, pp.914-956, 2010.
DOI : 10.1016/j.healun.2010.05.034

D. Mancini and K. Lietz, Selection of Cardiac Transplantation Candidates in 2010, Circulation, vol.122, issue.2, pp.173-83, 2010.
DOI : 10.1161/CIRCULATIONAHA.109.858076

R. Dorent, C. Cantrelle, and C. Jasseron, La greffe cardiaque en France??: bilan actuel, La Presse M??dicale, vol.43, issue.7-8, pp.813-822, 2014.
DOI : 10.1016/j.lpm.2014.03.017

R. Dorent, E. Epailly, and L. Sebbag, The effect of graft allocation system on outcomes in heart transplantation in France: Has the time come to take calculated survival benefit into account?, The Journal of Heart and Lung Transplantation, vol.30, issue.11, pp.1299-300, 2011.
DOI : 10.1016/j.healun.2011.06.008

K. Aaronson, J. Schwartz, and T. Chen, Development and Prospective Validation of a Clinical Index to Predict Survival in Ambulatory Patients Referred for Cardiac Transplant Evaluation, Circulation, vol.95, issue.12, pp.2660-2667, 1997.
DOI : 10.1161/01.CIR.95.12.2660

L. Lund, K. Aaronson, and D. Mancini, Predicting survival in ambulatory patients with severe heart failure on beta-blocker therapy, The American Journal of Cardiology, vol.92, issue.11, pp.1350-1354, 2003.
DOI : 10.1016/j.amjcard.2003.08.027

A. Goda, L. Lund, and D. Mancini, The Heart Failure Survival Score outperforms the peak oxygen consumption for heart transplantation selection in the era of device therapy, The Journal of Heart and Lung Transplantation, vol.30, issue.3, pp.315-340, 2011.
DOI : 10.1016/j.healun.2010.09.007

N. Banner, C. Rogers, and R. Bonser, Effect of Heart Transplantation on Survival in Ambulatory and Decompensated Heart Failure, Transplantation, vol.86, issue.11, pp.1515-1537, 2008.
DOI : 10.1097/TP.0b013e31818b3328

W. Levy, D. Mozaffarian, and D. Linker, The Seattle Heart Failure Model: Prediction of Survival in Heart Failure, Circulation, vol.113, issue.11, pp.1424-1457, 2006.
DOI : 10.1161/CIRCULATIONAHA.105.584102

J. Smits, E. De-vries, D. Pauw, and M. , Is it time for a cardiac allocation score? First results from the Eurotransplant pilot study on a survival benefit???based heart allocation, The Journal of Heart and Lung Transplantation, vol.32, issue.9, pp.873-80, 2013.
DOI : 10.1016/j.healun.2013.03.015

A. Goda, P. Williams, D. Mancini, and L. Lund, Selecting patients for heart transplantation: Comparison of the Heart Failure Survival Score (HFSS) and the Seattle Heart Failure Model (SHFM), The Journal of Heart and Lung Transplantation, vol.30, issue.11, pp.1236-1243, 2011.
DOI : 10.1016/j.healun.2011.05.012

R. Starling, Y. Naka, and A. Boyle, Results of the Post-U.S. Food and Drug Administration-Approval Study With a Continuous Flow Left Ventricular Assist Device as a Bridge to Heart Transplantation, Journal of the American College of Cardiology, vol.57, issue.19, pp.1890-1898, 2011.
DOI : 10.1016/j.jacc.2010.10.062

L. Stevenson, F. Pagani, and J. Young, INTERMACS Profiles of Advanced Heart Failure: The Current Picture, The Journal of Heart and Lung Transplantation, vol.28, issue.6, pp.535-576, 2009.
DOI : 10.1016/j.healun.2009.02.015

E. Barge-caballero, J. Segovia-cubero, and L. Almenar-bonet, Preoperative INTERMACS Profiles Determine Postoperative Outcomes in Critically Ill Patients Undergoing Emergency Heart Transplantation: Analysis of the Spanish National Heart Transplant Registry, Circulation: Heart Failure, vol.6, issue.4, pp.763-72, 2013.
DOI : 10.1161/CIRCHEARTFAILURE.112.000237

J. Kirklin, D. Naftel, L. Stevenson, R. Kormos, F. Pagani et al., INTERMACS Database for Durable Devices for Circulatory Support: First Annual Report, The Journal of Heart and Lung Transplantation, vol.27, issue.10, pp.1065-72, 2008.
DOI : 10.1016/j.healun.2008.07.021

J. Kirklin, D. Naftel, F. Pagani, R. Kormos, L. Stevenson et al., Sixth INTERMACS annual report: A 10,000-patient database, The Journal of Heart and Lung Transplantation, vol.33, issue.6, pp.555-64
DOI : 10.1016/j.healun.2014.04.010

E. Weiss, J. Allen, G. Arnaoutakis, T. George, S. Russell et al., Creation of a Quantitative Recipient Risk Index for Mortality Prediction After Cardiac Transplantation (IMPACT), The Annals of Thoracic Surgery, vol.92, issue.3, pp.914-921, 2011.
DOI : 10.1016/j.athoracsur.2011.04.030

A. Kilic, J. Allen, and E. Weiss, Validation of the United States???derived Index for Mortality Prediction After Cardiac Transplantation (IMPACT) using international registry data, The Journal of Heart and Lung Transplantation, vol.32, issue.5, pp.492-500, 2013.
DOI : 10.1016/j.healun.2013.02.001

P. Kamath, R. Wiesner, and M. Metal, A model to predict survival in patients with end-stage liver disease, Hepatology, vol.33, issue.2, pp.464-70, 2001.
DOI : 10.1053/jhep.2001.22172

P. Noly, A. Martin, A. Anselmi, and B. Lelong, Les scores pronostiques de mortalité pré et postgreffe sont-ils adaptés à notre pratique ? Résultats d'une étude monocentrique concernant le score SHFM, IMPACT et la classification INTERMACS, Chirurgie Thoracique et Cardio-Vasculaire, vol.19, issue.1, pp.44-52, 2015.

R. Bustami, A. Ojo, R. Wolfe, R. Merion, W. Bennett et al., Immunosuppression and the Risk of Post-Transplant Malignancy Among Cadaveric First Kidney Transplant Recipients, American Journal of Transplantation, vol.10, issue.1, pp.87-93, 2004.
DOI : 10.1097/00007890-200208150-00013

A. Zuckermann, U. Schulz, and T. Deuse, Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression, Transplant International, vol.26, issue.4 Pt 1, pp.259-69
DOI : 10.1111/tri.12480

P. Yerly, F. Mach, and A. Kalangos, Suivi du patient après transplantation cardiaque : monitoring et adaptation de l'immunosuppression, Rev Med Suisse, vol.5, pp.1214-1220, 2009.

C. Sommerer, T. Giese, J. Schmidt, S. Meuer, and M. Zeier, Ciclosporin A Tapering Monitored by NFAT-Regulated Gene Expression: A New Concept of Individual Immunosuppression, Transplantation, vol.85, issue.1, pp.15-21, 2008.
DOI : 10.1097/01.tp.0000296824.58884.55

L. Penninga, C. Møller, F. Gustafsson, D. Steinbrüchel, and C. Gluud, Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: systematic review with meta-analyses and trial sequential analyses of randomised trials, European Journal of Clinical Pharmacology, vol.331, issue.Suppl 1, pp.1177-1187, 2010.
DOI : 10.1007/s00228-010-0902-6

URL : https://hal.archives-ouvertes.fr/hal-00627922

J. Kobashigawa, L. Miller, and S. Russell, Tacrolimus with Mycophenolate Mofetil (MMF) or Sirolimus vs. Cyclosporine with MMF in Cardiac Transplant Patients: 1-Year Report, American Journal of Transplantation, vol.2, issue.3, pp.1377-86, 2006.
DOI : 10.1016/S0955-470X(03)00022-3

H. Lehmkuhl, U. Livi, and J. Arizon, 15: Results of a 12-Month, Multicenter, Randomized Trial of Everolimus with Reduced-Exposure Cyclosporine Versus MMF and Standard-Exposure Cyclosporine in De Novo Cardiac Transplant Recipients, The Journal of Heart and Lung Transplantation, vol.27, issue.2, p.65, 2008.
DOI : 10.1016/j.healun.2007.11.019

J. Kobashigawa, S. Katznelson, and H. Laks, Effect of Pravastatin on Outcomes after Cardiac Transplantation, New England Journal of Medicine, vol.333, issue.10, pp.621-6277, 1995.
DOI : 10.1056/NEJM199509073331003

A. Keogh, P. Macdonald, and A. Kaan, Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation, The Journal of Heart and Lung Transplantation, vol.19, issue.6, pp.529-537, 2000.
DOI : 10.1016/S1053-2498(00)00077-2

M. Schnoor, T. Schafer, D. Luhmann, and H. Sievers, Bicaval versus standard technique in orthotopic heart transplantation: A systematic review and meta-analysis, The Journal of Thoracic and Cardiovascular Surgery, vol.134, issue.5, pp.1322-1331, 2007.
DOI : 10.1016/j.jtcvs.2007.05.037

A. Iyer, . Kumarasinghe, and M. Hicks, Primary Graft Failure after Heart Transplantation, Journal of Transplantation, vol.8, issue.4, p.175768, 2011.
DOI : 10.1111/j.1432-2277.2011.01232.x

V. B. Dronavalli, C. A. Rogers, and N. R. Banner, Primary Cardiac Allograft Dysfunction???Validation of a Clinical Definition, Transplantation, vol.99, issue.9, 2015.
DOI : 10.1097/TP.0000000000000620

J. Kobashigawa, A. Zuckermann, P. Mac-donald, P. Leprince, F. Esmailian et al., Report from a consensus conference on primary graft dysfunction after cardiac transplantation, The Journal of Heart and Lung Transplantation, vol.33, issue.4, pp.327-340, 2014.
DOI : 10.1016/j.healun.2014.02.027

J. Segovia, M. Cosío, J. Barceló, M. Bueno, P. Pavía et al., RADIAL: A novel primary graft failure risk score in heart transplantation, The Journal of Heart and Lung Transplantation, vol.30, issue.6
DOI : 10.1016/j.healun.2011.01.721

S. F. Marasco, D. S. Esmore, and J. Negri, Early Institution of Mechanical Support Improves Outcomes in Primary Cardiac Allograft Failure, The Journal of Heart and Lung Transplantation, vol.24, issue.12, pp.2037-2042, 2005.
DOI : 10.1016/j.healun.2005.06.007

C. Carmena, M. , G. Bueno, M. Almenar, and L. , Primary graft failure after heart transplantation: Characteristics in a contemporary cohort and performance of the RADIAL risk score, The Journal of Heart and Lung Transplantation, vol.32, issue.12, pp.1187-95, 2013.
DOI : 10.1016/j.healun.2013.08.004

F. Weis, A. Beiras-fernandez, and I. Kaczmarek, Levosimendan: A New Therapeutic Option in the Treatment of Primary Graft Dysfunction After Heart Transplantation, The Journal of Heart and Lung Transplantation, vol.28, issue.5, pp.501-505, 2009.
DOI : 10.1016/j.healun.2009.01.017

S. Taghavi, A. Zuckermann, and J. Ankersmit, Extracorporeal Membrane Oxygenation is Superior to Right Ventricular Assist Device for Acute Right Ventricular Failure After Heart Transplantation, The Annals of Thoracic Surgery, vol.78, issue.5, pp.1644-1653, 2004.
DOI : 10.1016/j.athoracsur.2004.04.059

M. Pham, J. Teuteberg, and A. Kfoury, Gene-Expression Profiling for Rejection Surveillance after Cardiac Transplantation, New England Journal of Medicine, vol.362, issue.20, pp.1890-900, 2010.
DOI : 10.1056/NEJMoa0912965

M. Deng, H. Eisen, M. Mehra, M. Billingham, C. Marboe et al., Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression Profiling, American Journal of Transplantation, vol.4, issue.1, pp.150-160, 2006.
DOI : 10.1038/nrmicro1126

S. Stewart, M. Fishbein, and G. Snell, Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart Rejection, The Journal of Heart and Lung Transplantation, vol.24, issue.11, pp.1710-1730, 2005.
DOI : 10.1016/j.healun.2005.03.019

W. Uber, S. Self, V. Bakel, A. Pereira, and N. , Acute Antibody-Mediated Rejection Following Heart Transplantation, American Journal of Transplantation, vol.17, issue.9, pp.2064-2074, 2007.
DOI : 10.1097/01.TP.0000134398.86243.81

J. Kobashigawa, M. Crespo-leiro, S. Ensminger, H. Reichenspurner, A. Angelini et al., Report from a consensus conference on antibody-mediated rejection in heart transplantation, The Journal of Heart and Lung Transplantation, vol.30, issue.3, pp.252-269, 2011.
DOI : 10.1016/j.healun.2010.11.003

M. Rabant, P. Bruneval, D. Van-huyen, and J. , Anatomopathologie du rejet de greffe humoral en transplantation rénale et cardiaque. Revue francophone des laboratoires, Janv, vol.2014, 2014.

G. Berry, A. Angelini, M. Burke, P. Bruneval, M. Fishbein et al., The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: Evolution and current status (2005???2011), The Journal of Heart and Lung Transplantation, vol.30, issue.6, pp.601-611, 2005.
DOI : 10.1016/j.healun.2011.02.015

M. Mehra, M. Crespo-leiro, and A. Dipchand, International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy???2010, The Journal of Heart and Lung Transplantation, vol.29, issue.7, 2010.
DOI : 10.1016/j.healun.2010.05.017

J. Guihaire, E. Flécher, and C. Chababanne, Maladie coronaire du greffon : une complication silencieuse après transplantation cardiaque, Chirurgie thoracique et cardio-vasculaire, vol.18, issue.1, pp.33-42, 2014.

H. Eisen, E. Tuzcu, and R. Dorent, Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients, New England Journal of Medicine, vol.349, issue.9, pp.847-58, 2003.
DOI : 10.1056/NEJMoa022171

J. Fishman, Infection in Solid-Organ Transplant Recipients, New England Journal of Medicine, vol.357, issue.25, pp.2601-2615, 2007.
DOI : 10.1056/NEJMra064928

D. Collett, L. Mumford, N. Banner, J. Neuberger, and C. Watson, Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit, American Journal of Transplantation, vol.3, issue.Suppl 2, pp.1889-1896, 2010.
DOI : 10.1111/j.1600-6143.2010.03181.x

M. Guba, C. Graeb, K. Jauch, and E. Geissler, PRO- AND ANTI-CANCER EFFECTS OF IMMUNOSUPPRESSIVE AGENTS USED IN ORGAN TRANSPLANTATION, Transplantation, vol.77, issue.12, pp.1777-1782, 2004.
DOI : 10.1097/01.TP.0000120181.89206.54

J. Dantal, M. Hourmant, D. Cantarovich, M. Giral, G. Blancho et al., Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens, The Lancet, vol.351, issue.9103, pp.623-628, 1998.
DOI : 10.1016/S0140-6736(97)08496-1

R. Robson, J. M. Cecka, G. Opelz, M. Budde, and S. Sacks, Prospective Registry-Based Observational Cohort Study of the Long-Term Risk of Malignancies in Renal Transplant Patients Treated with Mycophenolate Mofetil, American Journal of Transplantation, vol.10, issue.12, pp.2954-2960, 2005.
DOI : 10.1111/j.1600-6143.2005.01125.x

J. Stehlik, L. Edwards, and A. Kucheryavaya, The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report???2011, The Journal of Heart and Lung Transplantation, vol.30, issue.10, pp.1078-94, 2011.
DOI : 10.1016/j.healun.2011.08.003

A. Keogh, P. Mac-donald, A. Kaan, C. Aboyoun, P. Spratt et al., Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation, The Journal of Heart and Lung Transplantation, vol.19, issue.6
DOI : 10.1016/S1053-2498(00)00077-2

L. Miller, F. Pagani, S. Russell, R. John, A. Boyle et al., Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation, New England Journal of Medicine, vol.357, issue.9, pp.885-96, 2007.
DOI : 10.1056/NEJMoa067758

E. Rose, A. Gelijns, and A. Moskowitz, Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure, New England Journal of Medicine, vol.345, issue.20, pp.1435-1478, 2001.
DOI : 10.1056/NEJMoa012175

S. Russell, J. Rogers, and C. Milano, Renal and Hepatic Function Improve in Advanced Heart Failure Patients During Continuous-Flow Support With the HeartMate II Left Ventricular Assist Device, Circulation, vol.120, issue.23, pp.2352-2359, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.814863

D. Taylor, J. Stehlik, and L. Edwards, Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report???2009, The Journal of Heart and Lung Transplantation, vol.28, issue.10, pp.1007-1029, 2009.
DOI : 10.1016/j.healun.2009.08.014

K. Lietz, R. John, and E. Burke, PRETRANSPLANT CACHEXIA AND MORBID OBESITY ARE PREDICTORS OF INCREASED MORTALITY AFTER HEART TRANSPLANTATION1, Transplantation, vol.72, issue.2, pp.277-83, 2001.
DOI : 10.1097/00007890-200107270-00020

J. Grimm, A. Kilic, and A. Shah, The influence of institutional volume on the incidence of complications and their effect on mortality after heart t r a n s p l a n t a t i o n, pp.1286-1289

J. Quin, M. Tauriainen, and L. Huber, Predictors of pericardial effusion after orthotopic heart transplantation, The Journal of Thoracic and Cardiovascular Surgery, vol.124, issue.5, pp.979-83, 2002.
DOI : 10.1067/mtc.2002.124387

A. Al-dadah, T. Guthrie, M. Pasque, M. Moon, G. Ewald et al., Clinical Course and Predictors of Pericardial Effusion Following Cardiac Transplantation, Transplantation Proceedings, vol.39, issue.5, pp.1589-1592, 2007.
DOI : 10.1016/j.transproceed.2006.11.014

P. Noly, A. Martin, and A. Anselmi, Comparaison des résultats de la greffe cardiaque avec priorité à ceux de la greffe sans priorité au CHU de Rennes, Chirurgie Thoracique et Cardio-Vasculaire, vol.19, issue.2, pp.77-88, 2015.

K. Hong, A. Iribarne, and B. Worku, Who Is the High-Risk Recipient? Predicting Mortality After Heart Transplant Using Pretransplant Donor and Recipient Risk Factors, The Annals of Thoracic Surgery, vol.92, issue.2, pp.520-527, 2011.
DOI : 10.1016/j.athoracsur.2011.02.086

T. Wittwer and T. Wahlers, Marginal donor grafts in heart transplantation: lessons learned from 25 years of experience, Transplant International, vol.53, issue.Suppl. 1, pp.113-125, 2008.
DOI : 10.1111/j.1432-2277.2007.00603.x

P. Vijay, V. Scavo, R. Morelock, T. Sharp, and J. Brown, Donor cardiac troponin T: a marker to predict heart transplant rejection, The Annals of Thoracic Surgery, vol.66, issue.6, pp.1934-1943, 1998.
DOI : 10.1016/S0003-4975(98)01057-1

J. Smits, D. Pauw, M. De-vries, and E. , Donor scoring system for heart transplantation and the impact on patient survival, The Journal of Heart and Lung Transplantation, vol.31, issue.4, pp.387-97, 2012.
DOI : 10.1016/j.healun.2011.11.005